Planned website maintenance is taking place from 11:00 pm AEDT on Friday 30 October to 6:00 am AEDT on Saturday 31 October 2026. Some pages may be temporarily unavailable. If issues continue outside this time, please contact us.
DAPSOMED (Medsurge Pharma Pty Ltd)
Product name
DAPSOMED
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
170 (255 working days)
Active ingredients
Dapsone
Registration type
New generic medicine
Indication
Dermatitis herpetiformis, Leprosy, and Actinomycotic mycetoma.